HUM
36
7
VRTX
57
8
RF
73
4
CME
49
-3
CLX
53
-2
HRL
47
2
APA
52
2
URI
50
7
MA
48
2
XOM
64
8
CAH
58
-3
MS
76
3
NTAP
65
-2
LH
53
-2
PM
52
-4
PPL
57
-2
NWL
61
3
COP
47
2
AES
45
-4
TSCO
48
3
HUM
36
7
VRTX
57
8
RF
73
4
CME
49
-3
CLX
53
-2
HRL
47
2
APA
52
2
URI
50
7
MA
48
2
XOM
64
8
CAH
58
-3
MS
76
3
NTAP
65
-2
LH
53
-2
PM
52
-4
PPL
57
-2
NWL
61
3
COP
47
2
AES
45
-4
TSCO
48
3
Financhill
Back

GeneDx Holdings Corp. 10K Form

Buy
60

WGS
GeneDx Holdings Corp.

Last Price:
$161.91
Seasonality Move:
91.11%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive WGS News And Ratings

See the #1 stock for the next 7 days that we like better than WGS

WGS Financial Statistics

Sales & Book Value

Annual Sales: $305.5M
Cash Flow: $9.6M
Price / Cash Flow: 297.39
Annual Sales: $10.12
Price / Book: 15.86

Profitability

EPS (TTM): 0.06030
Net Income (TTM): $2.1M
Gross Margin: $176.5M
Return on Equity: 0.82%
Return on Assets: 0.46%

GeneDx Holdings Corp. Earnings Forecast

Key GeneDx Holdings Corp. Financial Ratios

  • The Gross Profit Margin over the past 6 years for WGS is 57.78%.
  • The Selling, General & Administrative Expenses for WGS have been equal to 55.16% of Gross Profit Margin.
  • The Research & Development expenses have been 14.67% of Revenue.
  • The Net Earning history of WGS is -17.12% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 4 years.

GeneDx Holdings Corp. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: WGS
Website: genedx.com

Debt

Debt-to-Equity Ratio: 0.39
Current Ratio: 2.71
Quick Ratio: 2.47

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 320.75

WGS Technical Analysis vs Fundamental Analysis

Buy
60
GeneDx Holdings Corp. (WGS) is a Buy

Is GeneDx Holdings Corp. a Buy or a Sell?